| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CYCLOSPORINE | 216046 | 001 | ANDA | CYCLOSPORINE | CAPSULE;ORAL | 25MG | No | No | 2022/08/02 | 2022/08/02 | ONESOURCE SPECIALTY | Prescription |
| CYCLOSPORINE | 216046 | 002 | ANDA | CYCLOSPORINE | CAPSULE;ORAL | 50MG | No | No | 2022/08/02 | 2022/08/02 | ONESOURCE SPECIALTY | Prescription |
| CYCLOSPORINE | 216046 | 003 | ANDA | CYCLOSPORINE | CAPSULE;ORAL | 100MG | No | No | 2022/08/02 | 2022/08/02 | ONESOURCE SPECIALTY | Prescription |
| CYCLOSPORINE | 207606 | 001 | ANDA | CYCLOSPORINE | EMULSION;OPHTHALMIC | 0.05% | No | No | 2023/01/12 | 2023/01/12 | APOTEX | Discontinued |
| CYCLOSPORINE | 203880 | 001 | ANDA | CYCLOSPORINE | EMULSION;OPHTHALMIC | 0.05% | No | No | 2023/12/14 | 2023/12/14 | TEVA PHARMS USA INC | Prescription |
| CYCLOSPORINE | 209811 | 001 | ANDA | CYCLOSPORINE | EMULSION;OPHTHALMIC | 0.05% | No | No | 2024/05/21 | 2024/05/21 | DEVA HOLDING AS | Prescription |
| CYCLOSPORINE | 211943 | 001 | ANDA | CYCLOSPORINE | EMULSION;OPHTHALMIC | 0.05% | No | No | 2024/07/05 | 2024/07/05 | SAPTALIS PHARMS | Prescription |
| CYCLOSPORINE | 219049 | 001 | ANDA | CYCLOSPORINE | CAPSULE;ORAL | 25MG | No | No | 2025/09/15 | 2025/09/15 | QILU | Prescription |
| CYCLOSPORINE | 219049 | 002 | ANDA | CYCLOSPORINE | CAPSULE;ORAL | 100MG | No | No | 2025/09/15 | 2025/09/15 | QILU | Prescription |
| CYCLOSPORINE | 211909 | 001 | ANDA | CYCLOSPORINE | EMULSION;OPHTHALMIC | 0.05% | No | No | 2025/11/28 | -- | AMNEAL | Prescription |